GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Phoenix Biotech Acquisition Corp (NAS:PBAX) » Definitions » PB Ratio

Phoenix Biotech Acquisition (Phoenix Biotech Acquisition) PB Ratio : (As of May. 30, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Phoenix Biotech Acquisition PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-30), Phoenix Biotech Acquisition's share price is $5.85. Phoenix Biotech Acquisition's Book Value per Share for the quarter that ended in Sep. 2023 was $-0.88. Hence, Phoenix Biotech Acquisition's PB Ratio of today is .

The historical rank and industry rank for Phoenix Biotech Acquisition's PB Ratio or its related term are showing as below:

During the past 2 years, Phoenix Biotech Acquisition's highest PB Ratio was 11760.00. The lowest was 0.00. And the median was 0.00.

PBAX's PB Ratio is not ranked *
in the Diversified Financial Services industry.
Industry Median: 1.86
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Phoenix Biotech Acquisition's average Book Value Per Share Growth Rate was -111.80% per year.

Back to Basics: PB Ratio


Phoenix Biotech Acquisition PB Ratio Historical Data

The historical data trend for Phoenix Biotech Acquisition's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phoenix Biotech Acquisition PB Ratio Chart

Phoenix Biotech Acquisition Annual Data
Trend Dec21 Dec22
PB Ratio
1.33 28.14

Phoenix Biotech Acquisition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.36 28.14 36.33 134.57 -

Competitive Comparison of Phoenix Biotech Acquisition's PB Ratio

For the Shell Companies subindustry, Phoenix Biotech Acquisition's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phoenix Biotech Acquisition's PB Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Phoenix Biotech Acquisition's PB Ratio distribution charts can be found below:

* The bar in red indicates where Phoenix Biotech Acquisition's PB Ratio falls into.



Phoenix Biotech Acquisition PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Phoenix Biotech Acquisition's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2023)
=5.85/-0.877
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Phoenix Biotech Acquisition  (NAS:PBAX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Phoenix Biotech Acquisition PB Ratio Related Terms

Thank you for viewing the detailed overview of Phoenix Biotech Acquisition's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Phoenix Biotech Acquisition (Phoenix Biotech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
2201 Broadway, Suite 705, Oakland, CA, USA, 94612
Website
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe.
Executives
Caroline M Loewy director 300 ELLIOTT AVE WEST, SUITE 500, SEATTLE WA 98119-4114
Brian G Atwood director ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104
Kathleen Laporte director
Christopher B Ehrlich director, 10 percent owner, officer: CEO and and Secretary 499 ILLINOIS STREET, SUITE 200, SAN FRANCISCO CA 94158
Douglas Fisher officer: President 587 PATROL RD, WOODSIDE CA 94062
Daniel E. Geffken officer: Chief Financial Officer DAMONMILL SQUARE, SUITE 6A, CONCORD MA 01742
Barbara Kosacz director 3175 HANOVER STREET, PALO ALTO CA 94304
Phoenix Biotech Sponsor, Llc 10 percent owner 2001 MARKET STREET, SUITE 3400, PHILADELPHIA PA 19103